A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...
The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback